Anle138b to target the toxic protein in Parkinson’s

[SuzeCP]

In Parkinson’s, a protein called alpha-synuclein which is abundant in nerve cells, begins clumping together (or aggregating) and it is believed that this process could be toxic. Anle138b is a small molecule that has been developed, by the German biotech company MODAG, to inhibit alpha-synuclein aggregation; and it is hoped that this treatment will slow-down or halt the progression of Parkinson’s.

bit.ly/3mxnBtq

[Hidden]

scienceofparkinsons.com/202...

[Ponieboy in reply to Hidden]

Good read.. perhaps something will come out of it soon.

[Despe]

Haven't they run out of "mice models" yet?

[goldengrove]

That's interesting. Until this is shown to help PwPs and becomes available, I wonder whether it gives more credence to the use of curcumin which has also been shown to lessen the clumping of alpha-synuclein in vitro and in mouse models?

[Smittybear7]

Interesting article. Keep the information coming. Thanks for sharing

[Hidden]

healthunlocked.com/cure-par...

[Boscoejean]

clinicaltrials.gov/ct2/show...